Download 36th Hemophilia Symposium Hamburg 2005: Epidemiology; by Inge Scharrer, Wolfgang Schramm, G. Auerswald, A. Kurth, J. PDF

By Inge Scharrer, Wolfgang Schramm, G. Auerswald, A. Kurth, J. Oldenburg, W. Schramm, B. Zieger

This publication comprises the contribution to the thirty sixth Hemophilia Symposium, Hamburg 2005. the most issues are epidemiolgy, hemophilia treatment, orthopedic therapy in hemophiliacs, hemostaseologic analysis and pediatric hemostaseology. the amount is rounded off through various loose papers and posters on hemophilia, inhibitors in hemophilia and diagnostics.

Show description

Read Online or Download 36th Hemophilia Symposium Hamburg 2005: Epidemiology; Hemophilia Therapy - Management of Bleedings and Inhibitors; Orthopedic Treatment in Hemophiliacs; ... Pediatric Hemostaseology; Free Lectures PDF

Similar therapy books

The Collected Papers of Milton H. Erickson, Volumes 1-8

This all-inclusive CD-ROM comprises 8 absolutely up to date works of Milton H. Erickson, M. D. This easy-to-use software program offers material starting from hypnosis to psychodynamics, unorthodox treatment, and mind-body therapeutic. Erickson's experimental and healing explorations with the hypnotic modality span over 50 years.

Clinical Handbook of Couple Therapy (5th Edition)

Considered as the authoritative reference and textual content, this guide offers the simplest, largely studied methods to couple remedy. the celebrated coeditors compile different best specialists, such a lot of whom constructed the methods they describe. Adhering heavily to a uniform constitution to facilitate learn and comparability, chapters disguise the historical past, theoretical and empirical underpinnings, and methods of every version.

The Healing Bond: The Patient-Practitioner Relationship and Therapeutic Responsibility

The growing to be approval for replacement cures poses difficult questions for the clinical institution and the nation. via confronting those questions, The therapeutic Bond makes a massive contribution to present debates approximately future health care. The individuals, who're all specialists within the fields of future health care, social technology and the legislation, concentrate on the connection among sufferer and healer in either orthodox and non-orthodox types of therapeutic perform.

Extra resources for 36th Hemophilia Symposium Hamburg 2005: Epidemiology; Hemophilia Therapy - Management of Bleedings and Inhibitors; Orthopedic Treatment in Hemophiliacs; ... Pediatric Hemostaseology; Free Lectures

Sample text

Van DK, van der Bom JG, Lenting PJ, de Groot PG, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, van den Berg HM. Factor VIII half-life and clinical phenotype of severe hemophilia A. Haematologica 2005; 90: 494–8. 29. Vlot AJ, Mauser-Bunschoten EP, Zarkova AG, Haan E, Kruitwagen CL, Sixma JJ, van den Berg HM. The half-life of infused factor VIII is shorter in hemophilic patients with blood group O than in those with blood group A. Thromb Haemost 2000; 83: 65–9. 30. Bjorkman S, Berntorp E. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.

Prof. Landesklinikum St. Pölten, A-St. Pölten I. Epidemiology Chairmen: L. Gürtler (Greifswald) W. Schramm (Munich) HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2004/2005 Survey) H. Krebs, and W. Schramm on Behalf of the Participating German Hemophilia centers Introduction The annually survey »HIV Infection and Causes of Death in Patients with Hemophilia in Germany« already goes along with a fine tradition. Already in the late 1970s Professor Landbeck began to survey annually hemophiliacs in West Germany for causes of death and the prevalence of diseases.

Regarding data back to 1999 the inhibitor prevalence observed in our cohort is slightly declining as depicted in Figure 3. Combining these data with further data of other authors and surveys presented at the Hamburg Hemophilia-Symposium since 1978 (see Fig. 5 % successful immune tole- H. Krebs, W. Schramm % F:VIII inhibitors 6 Fig. 3. Prevalence of patients with hemophilia A and inhibitors since 1999 rance therapies per year there is also no indication of an increasing prevalence of inhibitors in patients with hemophilia A.

Download PDF sample

Rated 4.13 of 5 – based on 43 votes